Dexcom tests its diabetes monitor on Apple Watch; Surgery for spinal stenosis may not be very beneficial;

@FierceMedDev: Roche snatches up majority share in Foundation Medicine for $1B plus milestones. Report from FierceDiagnostics | Follow @FierceMedDev

@StacyALawrence: ICYMI yesterday: JP Morgan: With $1.5B spent and a new president, NantHealth works to rationalize patient care. Article | Follow @StacyALawrence

> Dexcom ($DXCM) demoed its continuous glucose monitor on the Apple Watch. Story

> A study found long-term outcomes in spinal stenosis patients are similar among patients who opt for surgery and those who choose a more conservative approach. Story

> A study of market leading intraocular lenses manufactured by Carl Zeiss and Alcon found that patients were equally satisfied with both. Story

Biotech News

@FierceBiotech: $ALNY and $ISIS strengthen RNAi alliance, agree to swap IP. FierceDrugDelivery article | Follow @FierceBiotech

@JohnCFierce: Last night I had to hug a wall to allow a stampede of biotech execs to surround the NY Times' Pollack. Dangerous work here at #JPM15. | Follow @JohnCFierce

> FDA steps in after a patient on Antares' 'low-T' drug breaks out in hives. Story

> Roche inks a $750M antibiotics deal as it re-embraces the field. Article

Pharma News

@FiercePharma: ICYMI: Is once-skeptical J&J coming around on pharma's breakup craze? More | Follow @FiercePharma

@CarlyHFierce: Merck CEO Frazier credits Keytruda success to slim-down strategy. Article | Follow @CarlyHFierce

> Shire's deal for NPS hasn't curbed its M&A appetite. News

> Thanks to hep C pricing war, Gilead, AbbVie both score spots on Prime's coverage list. More

Biotech Research News

> Investigators electrify antibiotic R&D field with claims of a breakthrough. News

> Team takes a new approach to taming neuroinflammation. Article

> Amgen teams with MD Anderson on new BiTE programs for MDS. Story

> Scientists uncover new target for triple-negative breast cancer. Article

> Scripps researchers find a better way to make a nicotine vaccine. Report

Pharma Manufacturing News

> FDA upgrades Fresenius sterile plant once cited for insect infestation. Story

> AmerisourceBergen moving into vet drug distribution with $2.5B deal for MWI. News

> Group wants FDA to include Indian regulators on plant visits. More

> FDA stops import of Lilly's Cialis from Australia but Lilly says it doesn't make it there. Story

> AMRI buys more manufacturing capacity with deal for two Aptuit facilities. Article

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.